These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 11606491)

  • 21. Serum antibodies against Helicobacter pylori proteins VacA and CagA are associated with increased risk for gastric adenocarcinoma.
    Rudi J; Kolb C; Maiwald M; Zuna I; von Herbay A; Galle PR; Stremmel W
    Dig Dis Sci; 1997 Aug; 42(8):1652-9. PubMed ID: 9286230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of gastric carcinoma risk associated with Helicobacter pylori may vary depending on the antigen used: CagA specific enzyme-linked immunoadsorbent assay (ELISA) versus commercially available H. pylori ELISAs.
    Maeda S; Yoshida H; Ogura K; Yamaji Y; Ikenoue T; Mitsushima T; Tagawa H; Kawaguchi R; Mori K; Mafune Ki; Kawabe T; Shiratori Y; Omata M
    Cancer; 2000 Apr; 88(7):1530-5. PubMed ID: 10738209
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Infection with CagA+ Helicobacter pylori strains as a possible predictor of risk in the development of gastric adenocarcinoma in Mexico.
    Torres J; Pérez-Pérez GI; Leal-Herrera Y; Muñoz O
    Int J Cancer; 1998 Oct; 78(3):298-300. PubMed ID: 9766561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The pattern of CagA and VacA proteins in Helicobacter pylori seropositive asymptomatic children in western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2005 Sep; 26(9):1372-7. PubMed ID: 16155650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of nuclear factor-kappa B and target genes in gastric precancerous lesions and adenocarcinoma: association with Helicobactor pylori cagA (+) infection.
    Yang GF; Deng CS; Xiong YY; Gong LL; Wang BC; Luo J
    World J Gastroenterol; 2004 Feb; 10(4):491-6. PubMed ID: 14966904
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of gastrin in gastric cancerogenesis in Helicobacter pylori infected humans.
    Konturek PC; Konturek SJ; Bielanski W; Karczewska E; Pierzchalski P; Duda A; Starzynska T; Marlicz K; Popiela T; Hartwich A; Hahn EG
    J Physiol Pharmacol; 1999 Dec; 50(5):857-73. PubMed ID: 10695565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibody against Helicobacter pylori CagA and VacA and the risk for gastric cancer.
    Yamaoka Y; Kodama T; Kashima K; Graham DY
    J Clin Pathol; 1999 Mar; 52(3):215-8. PubMed ID: 10450182
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Helicobacter pylori infection combined with CagA and pepsinogen status on gastric cancer development among Japanese men and women: a nested case-control study.
    Sasazuki S; Inoue M; Iwasaki M; Otani T; Yamamoto S; Ikeda S; Hanaoka T; Tsugane S;
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1341-7. PubMed ID: 16835334
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Seropositivity against Helicobacter pylori CagA in Turkish gastric cancer patients.
    Gürbüz AK; Ozel AM; Yazgan Y; Günay A; Ozdemir S; Demirtürk L; Emekdaş G
    J Clin Gastroenterol; 2001; 33(5):389-92. PubMed ID: 11606855
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Helicobacter pylori infection assessed by ELISA and by immunoblot and noncardia gastric cancer risk in a prospective study: the Eurgast-EPIC project.
    González CA; Megraud F; Buissonniere A; Lujan Barroso L; Agudo A; Duell EJ; Boutron-Ruault MC; Clavel-Chapelon F; Palli D; Krogh V; Mattiello A; Tumino R; Sacerdote C; Quirós JR; Sanchez-Cantalejo E; Navarro C; Barricarte A; Dorronsoro M; Khaw KT; Wareham N; Allen NE; Tsilidis KK; Bas Bueno-de-Mesquita H; Jeurnink SM; Numans ME; Peeters PHM; Lagiou P; Valanou E; Trichopoulou A; Kaaks R; Lukanova-McGregor A; Bergman MM; Boeing H; Manjer J; Lindkvist B; Stenling R; Hallmans G; Mortensen LM; Overvad K; Olsen A; Tjonneland A; Bakken K; Dumeaux V; Lund E; Jenab M; Romieu I; Michaud D; Mouw T; Carneiro F; Fenge C; Riboli E
    Ann Oncol; 2012 May; 23(5):1320-1324. PubMed ID: 21917738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of Helicobacter pylori cagA Gene with Gastric Cancer and Peptic Ulcer in Saudi Patients.
    Saber T; Ghonaim MM; Yousef AR; Khalifa A; Al Qurashi H; Shaqhan M; Samaha M
    J Microbiol Biotechnol; 2015 Jul; 25(7):1146-53. PubMed ID: 25791852
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relation between histologic subtypes and location of gastric cancer and Helicobacter pylori.
    Martín-de-Argila C; Boixeda D; Redondo C; Alvarez I; Gisbert JP; García Plaza A; Cantón R
    Scand J Gastroenterol; 1997 Apr; 32(4):303-7. PubMed ID: 9140150
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum antibodies to Helicobacter pylori and the CagA antigen do not explain differences in the prevalence of precancerous gastric lesions in two Chinese populations with contrasting gastric cancer rates.
    Groves FD; Perez-Perez G; Zhang L; You WC; Lipsitz SR; Gail MH; Fraumeni JF; Blaser MJ
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1091-4. PubMed ID: 12376512
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Helicobacter pylori strain types and risk of gastric cancer: a case-control study.
    Enroth H; Kraaz W; Engstrand L; Nyrén O; Rohan T
    Cancer Epidemiol Biomarkers Prev; 2000 Sep; 9(9):981-5. PubMed ID: 11008919
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Helicobacter pylori vacA s1, m1 genotype and cagA is associated with gastric carcinoma in Germany.
    Miehlke S; Kirsch C; Agha-Amiri K; Günther T; Lehn N; Malfertheiner P; Stolte M; Ehninger G; Bayerdörffer E
    Int J Cancer; 2000 Aug; 87(3):322-7. PubMed ID: 10897035
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of gastric cancer among smokers infected with Helicobacter pylori.
    Brenner H; Arndt V; Bode G; Stegmaier C; Ziegler H; Stümer T
    Int J Cancer; 2002 Mar; 98(3):446-9. PubMed ID: 11920598
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation of anti-Helicobacter pylori cagA IgG antibodies with resistance to first line treatment, bleeding gastroduodenal ulcers and gastric cancer.
    Ilie M; Dascălu L; Chifiriuc C; Popa M; Constantinescu G; Tănăsescu C; Baltac A
    Roum Arch Microbiol Immunol; 2011; 70(3):101-4. PubMed ID: 22570922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prospective study of Helicobacter pylori antigens and gastric noncardia cancer risk in the nutrition intervention trial cohort.
    Murphy G; Freedman ND; Michel A; Fan JH; Taylor PR; Pawlita M; Qiao YL; Zhang H; Yu K; Abnet CC; Dawsey SM
    Int J Cancer; 2015 Oct; 137(8):1938-46. PubMed ID: 25845708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age and severity of mucosal lesions influence the performance of serologic markers in Helicobacter pylori-associated gastroduodenal pathologies.
    Camorlinga-Ponce M; Flores-Luna L; Lazcano-Ponce E; Herrero R; Bernal-Sahagún F; Abdo-Francis JM; Aguirre-García J; Muñoz N; Torres J
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2498-504. PubMed ID: 18768521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.